Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9720187 | 0.91 | ALDH1A1 (0.39) | TSHRTDP1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL5181525 | 0.81 | — | — | |
| SCHEMBL1657137 | 0.80 | ALDH1A1 (0.53) | TSHRALDH1A1SMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL1052850 | 0.80 | ALDH1A1 (0.38) | TSHRALDH1A1SMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL1658306 | 0.80 | ALDH1A1 (0.45) | TSHRTDP1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL1051731 | 0.80 | ALDH1A1 (0.50) | TSHRALDH1A1SMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL26118 | 0.79 | — | — | |
| SCHEMBL16786319 | 0.79 | — | — | |
| SCHEMBL19501042 | 0.79 | — | — | |
| SCHEMBL19492611 | 0.78 | TRPV1 (0.39) | TSHRTDP1TRPA1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6686331-B2 | PRINCIPAL SOLVENTS, ESPECIALLY MONO AND DIOL PRINCIPAL SOLVENTS, HAVING A SPECIFIED CLOGP VALUE, SPECIFIED TYPES OF SOFTENERS SUCH AS VARISOFT?, WATER AND OPTIONAL ADDITIVES; PREMIX | THE PROCTER & GAMBLE COMPANY | 2004-02-03 | — | — | US | claimed |
| CN-1110541-C | Concentrated water-dispersible stable fiber softener compositions | PROCTER & GAMBLE (US) | 2003-06-04 | — | — | CN | claimed |
| CN-1098350-C | Fabric softening compound/composition | PROCTER & GAMBLE (US) | 2003-01-08 | — | — | CN | claimed |
| CN-1244212-A | Improved expression vectors | PROCTER & GAMBLE (US) | 2000-02-09 | — | — | CN | claimed |
| CN-1219953-A | Fabric softening compound/composition | PROCTER & GAMBLE (US) | 1999-06-16 | — | — | CN | claimed |
| CN-1196081-A | Concentrated, water dispersible, stable, fabric softening compositions | PROCTER & GAMBLE (US) | 1998-10-14 | — | — | CN | claimed |
| CN-1195369-A | Concentrated and stable fabric softening compositions | PROCTER & GAMBLE (US) | 1998-10-07 | — | — | CN | claimed |
| EP-0842250-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | claimed |
| EP-0839179-A1 | CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-06 | — | — | EP | claimed |
| WO-1997003170-A1 | CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | claimed |
| WO-1997003169-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | claimed |
| US-20260096985-A1 | Injectable Composition For Drug Delivery | CELANESE EVA PERFORMANCE POLYMERS LLC | 2026-04-09 | — | — | US | disclosed |
| US-20260097150-A1 | Implantable Device for Treating an Ocular Condition | CELANESE EVA PERFORMANCE POLYMERS LLC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260096984-A1 | Implantable Device for Administering a Therapeutic Agent | CELANESE EVA PERFORMANCE POLYMERS LLC (US) | 2026-04-09 | — | — | US | disclosed |
| EP-3895651-A1 | ELASTOMER THERMOPLASTIC ANTIMICROBIAL FILM, COMPOSITION AND MANUFACTURING METHOD FOR OBTAINING SAME | Hexis (FR) | 2021-10-20 | — | — | EP | disclosed |
| EP-0006627-A2 | Radiation-sensitive mixture and process for producing relief images | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-01-09 | — | — | EP | disclosed |
| US-4180646-A | BIOERODABLE SUSTAINED RELEASE COTAINGS | ALZA CORPORATION (US) | 1979-12-25 | — | — | US | disclosed |
| US-4138344-A | Erodible agent releasing device comprising poly(orthoesters) and poly(orthocarbonates) | ALZA CORPORATION (US) | 1979-02-06 | — | — | US | disclosed |
| US-4131648-A | POLYMERIC MATERIALS | ALZA CORPORATION (US) | 1978-12-26 | — | — | US | disclosed |
| US-4093709-A | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) | ALZA CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097150-A1 | Implantable Device for Treating an Ocular Condition | P4HTM, ITGAM, TIMM44 | TSHR 1042/4885TDP1 3398/4885TRPA1 484/4885 |
| US-20260096984-A1 | Implantable Device for Administering a Therapeutic Agent | GHITM, O60361, P4HTM | TSHR 298/4885TDP1 1619/4885TRPA1 1501/4885 |
| US-20260096985-A1 | Injectable Composition For Drug Delivery | SAMM50, OPRM1, IRAK4 | TSHR 356/4885TDP1 2560/4885TRPA1 2583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.